Contact Molecules for Homologous Proteins | ||||
[Full Bars] |
[SiteTable] |
|
[Back to Search Page] |
[Back to HOMCOS] |
[SupCon3D] |
[help] |
seq_id(%): [0] [30] [40] [50] [60] [70] [80] [90] [95] [100] | [show] [download] [help] |
PID | QueryLength | Homolgous Sequence in PDB | UniProt Query | TITLE |
2931865 | 365 | 500 | P04439(HLAA_HUMAN) | RecName: Full=HLA class I histocompatibility antigen, A alpha chain;AltName: Full=Human leukocyte antigen A; Short=HLA-A;Flags: Precursor; |
QUERYSEQ |
MAVMAPRTLLLLLSGALALTQTWAGSHSMRYFFTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGPEYWDQETRNVKAQSQTDRVDLGTLRGYYNQSEAGSHTIQIMYGCDVGSDGRFLRGYRQDAYDGKDYIAL NEDLRSWTAADMAAQITKRKWEAAHEAEQLRAYLDGTCVEWLRRYLENGKETLQRTDPPKTHMTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGEEQRYTCHVQHEGLPKPLTLRWEL SSQPTIPIVGIIAGLVLLGAVITGAVVAAVMWRRKSSDRKGGSYTQAASSDSAQGSDVSLTACKV |
365 | region | name | description |
1-24 | SIGNAL | ||
25-365 | CHAIN | /note="HLA class I histocompatibility antigen, A alpha chain" /id="PRO_0000018815" | |
25-308 | TOPO_DOM | /note="Extracellular" | |
309-332 | TRANSMEM | /note="Helical" | |
333-365 | TOPO_DOM | /note="Cytoplasmic" | |
209-295 | DOMAIN | /note="Ig-like C1-type" | |
3-11 | REGION | /note="VL9 epitope" | |
25-114 | REGION | /note="Alpha-1" | |
115-206 | REGION | /note="Alpha-2" | |
207-298 | REGION | /note="Alpha-3" | |
299-308 | REGION | /note="Connecting peptide" | |
339-365 | REGION | /note="Disordered" | |
341-359 | COMPBIAS | /note="Polar residues" | |
31-31 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" | |
97-97 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" | |
108-108 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" | |
140-140 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="2" /ligand_note="self-peptide antigen" | |
167-167 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" | |
170-170 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" | |
183-183 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" | |
183-183 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="2" /ligand_note="self-peptide antigen" | |
195-195 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" | |
1-365 | DISORDER | predicted by DISOPRED |
MONOMER | |||||||
365 | |||||||
pdb_id | a1 | identity[%]2 | description | ||||
6o9c | A | 99.6 | 1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha chain | ||||
1.a1:asym_id for the homologue. 2.identity[%]2:sequence identity between the query and the homologue. |
HETERO | |||||||
365 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
1qvo[3] | C | NEF_HV1Z6 Negative factor[10 aa] | A | 89.3 /97.5 |
28 /28 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. | |
2xpg[1] | C | MYPR_HUMAN MYELIN PROTEOLIPID PROTEIN[9 aa] | A | 100.0 /100.0 |
26 /26 |
1A03_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-3 ALPHA .. | |
5wkf[9] | E | D30 TCR beta chain[244 aa] | A | 100.0 /97.4 |
10 /10 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. | |
6eny[1] | B | TPSN_HUMAN Tapasin[364 aa] | D | 100.0 /100.0 |
11 /11 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. | |
6eny[1] | E | CALR_HUMAN Calreticulin[365 aa] | D | 100.0 /100.0 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. | |
7qpd[1] | E | CALR_HUMAN Calreticulin[364 aa] | D | 100.0 /100.0 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. | |
7l1b[1] | C | PK3CA_HUMAN wild-type PIK3CA peptide[9 aa] | A | 100.0 /100.0 |
24 /24 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
7l1c[3] | C | PK3CA_HUMAN mutant PIK3CA peptide[9 aa] | A | 100.0 /100.0 |
28 /28 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
7l1d[1] | D | T cell receptor, alpha chain[187 aa] | A | 100.0 /100.0 |
6 /6 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
7l1d[1] | E | T cell receptor, beta chain[247 aa] | A | 100.0 /100.0 |
12 /12 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
7mle[1] | C | NCAP_INBAC Nucleoprotein peptide[9 aa] | A | 100.0 /100.0 |
25 /25 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
7ow3[3] | C | RASN_HUMAN KRAS peptide (VVVGAGGVGK)[10 aa] | A | 87.0 /97.4 |
23 /23 |
A0A583ZB34_HUMAN MHC class I antigen | |
8dvg[1] | C | VAL-VAL-VAL-GLY-ALA-GLY-GLY-VAL-GLY-LYS[10 aa] | A | 100.0 /100.0 |
23 /23 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. | |
7qpd[1] | B | TPSN_HUMAN Tapasin[348 aa] | D | 100.0 /100.0 |
26 /26 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. | |
7qpd[1] | C | PDIA3_HUMAN Protein disulfide-isomerase A3[459 aa] | D | 100.0 /100.0 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. | |
7qpj[1] | E | T-cell receptor beta chain[238 aa] | A | 100.0 /93.1 |
6 /6 |
Q861F7_HUMAN MHC class I antigen | |
8rym[3] | E | TCR beta[238 aa] | A | 100.0 /100.0 |
5 /5 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
7rrg[1] | C | T cell receptor, alpha chain[185 aa] | A | 100.0 /100.0 |
10 /10 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
7stf[1] | A | IgG, Fab Heavy Chain V2[216 aa] | D | 100.0 /100.0 |
16 /16 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
7stf[1] | B | KRAS G12V (7-16)[10 aa] | D | 100.0 /100.0 |
19 /19 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
7stf[1] | C | IgG, Fab Light Chain V2[214 aa] | D | 100.0 /100.0 |
8 /8 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
7uc5[2] | C | NCAP_I46A1 Nucleoprotein peptide[9 aa] | A | 100.0 /100.0 |
30 /30 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
8rym[3] | D | TCR alpha[178 aa] | A | 100.0 /100.0 |
5 /5 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
8vr9[1] | C | RASK_HUMAN GTPase KRas, N-terminally processed[9 aa] | A | 100.0 /100.0 |
22 /22 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
6o9c[1] | C | CTNB1_HUMAN Catenin beta-1[9 aa] | A | 100.0 /99.6 |
23 /23 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. | |
6o9b[1] | C | CTNB1_HUMAN Catenin beta-1[9 aa] | A | 100.0 /99.6 |
22 /22 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. | |
7m8t[1] | C | SPIKE_SARS2 Spike protein S1 peptide[9 aa] | A | 88.0 /97.5 |
25 /25 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
4uq2[2] | F | AZOBENZENE-CONTAINING PEPTIDE[7 aa] | A | 76.9 /97.5 |
13 /13 |
1A11_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-11 ALPHA.. | |
6id4[2] | G | Heavy chain[216 aa] | A | 100.0 /97.4 |
10 /10 |
F6IQY1_HUMAN MHC class I antigen | |
6id4[2] | H | Light chain[216 aa] | A | 75.0 /97.4 |
4 /4 |
F6IQY1_HUMAN MHC class I antigen | |
7ow6[1] | D | TCR alpha[181 aa] | A | 91.7 /97.5 |
12 /12 |
A0A583ZB34_HUMAN MHC class I antigen | |
7s8r[2] | C | M1_INBAC Matrix protein 1 peptide SALEWIKNK[9 aa] | A | 84.6 /97.5 |
26 /26 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
8rbu[1] | C | SPIKE_SARS2 Spike protein S2' [10 aa] | A | 87.5 /97.5 |
32 /32 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen | |
8rh6[3] | I | SPIKE_SARS2 Spike protein S2' [10 aa] | A | 86.7 /97.5 |
30 /30 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen | |
8rym[6] | C | ELFSYLIEK peptide[9 aa] | A | 100.0 /100.0 |
31 /31 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
8ryp[3] | D | TCR alpha[190 aa] | A | 100.0 /100.0 |
6 /6 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
8ryp[3] | E | TCR beta[237 aa] | A | 100.0 /100.0 |
7 /7 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
1x7q[2] | C | NCAP_CVHSA SARS NUCLEOCAPSID PEPTIDE[9 aa] | A | 89.7 /97.5 |
29 /29 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. | |
2hn7[1] | C | DNA polymerase PEPTIDE HOMOLOGUE[10 aa] | A | 88.0 /97.4 |
25 /25 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. | |
4mj5[1] | C | R4P6M5_9INFA Nucleocapsid protein[11 aa] | A | 85.2 /97.4 |
27 /27 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. | |
4mj6[1] | C | R4X2K3_9INFA Nucleoprotein[11 aa] | A | 84.0 /97.4 |
25 /25 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. | |
4n8v[2] | A | KI2S2_HUMAN Killer cell immunoglobulin-like receptor 2DS2[190 .. | C | 100.0 /97.4 |
11 /11 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. | |
4n8v[2] | E | A14_VACCW peptide from Virion membrane protein A14[9 aa] | C | 86.7 /97.4 |
30 /30 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. | |
5grd[1] | C | Epstein Barr Virus, Latent membrane protein 2 epit.. | A | 84.6 /97.4 |
26 /26 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. | |
5grg[1] | C | Epstein Barr Virus, Latent Membrane Protein 2 epit.. | A | 84.6 /97.4 |
13 /13 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. | |
5grg[1] | D | Epstein Barr Virus, Latent Membrane Protein 2 epit.. | A | 81.8 /97.4 |
11 /11 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. | |
5gsd[1] | C | Epstein Barr Virus, Latent membrane protein-2 epit.. | A | 88.9 /97.4 |
18 /18 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. | |
5wjl[5] | C | GTS1 peptide[10 aa] | A | 92.6 /97.4 |
27 /27 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. | |
5wjn[5] | C | GTS3 peptide[10 aa] | A | 86.7 /97.4 |
30 /30 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. | |
5wkf[4] | D | A0A087WSZ9_HUMAN K7N5N2_HUMAN T-cell receptor alpha variable 30,T-cell receptor,.. | A | 75.0 /97.4 |
4 /4 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. | |
6joz[1] | C | ALA-THR-ILE-GLY-THR-ALA-MET-TYR-LYS[9 aa] | A | 85.2 /97.4 |
27 /27 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. | |
6jp3[1] | C | ALA-THR-ILE-GLY-THR[5 aa] | A | 76.9 /97.4 |
13 /13 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. | |
6jp3[1] | D | ALA-MET-TYR-LYS[4 aa] | A | 84.6 /97.4 |
13 /13 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. | |
7ow3[1] | F | RASN_HUMAN KRAS peptide (VVVGAGGVGK)[7 aa] | D | 91.3 /97.4 |
23 /23 |
A0A583ZB34_HUMAN MHC class I antigen | |
7ow3[1] | I | RASN_HUMAN KRAS peptide (VVVGAGGVGK)[6 aa] | G | 90.9 /97.4 |
22 /22 |
A0A583ZB34_HUMAN MHC class I antigen | |
7ow4[4] | C | RASN_HUMAN KRAS G12D peptide (VVVGADGVGK)[8 aa] | A | 90.9 /97.5 |
22 /22 |
A0A583ZB34_HUMAN MHC class I antigen | |
7ow5[1] | D | TCR alpha[191 aa] | A | 91.7 /97.4 |
12 /12 |
A0A583ZB34_HUMAN MHC class I antigen | |
7ow5[4] | E | TCR beta[246 aa] | A | 100.0 /97.4 |
5 /5 |
A0A583ZB34_HUMAN MHC class I antigen | |
7ow6[3] | C | RASN_HUMAN KRAS G12D peptide (VVVGADGVGK)[10 aa] | A | 88.5 /97.5 |
26 /26 |
A0A583ZB34_HUMAN MHC class I antigen | |
7pb2[2] | D | TCR alpha[163 aa] | A | 90.0 /97.4 |
10 /10 |
A0A583ZB34_HUMAN MHC class I antigen | |
7s8q[2] | C | NCAP_INBSI Nucleoprotein peptide KTNGNAFIGK[10 aa] | A | 85.7 /97.5 |
28 /28 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
7s8s[1] | C | NS1_INBSJ Non-structural protein 1 peptide RVLVNGTFLK[10 aa].. | A | 87.1 /97.4 |
31 /31 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
8i5c[17] | C | peptide KRAS-G12V-9[9 aa] | A | 81.8 /96.7 |
22 /22 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) | |
8vr9[3] | D | R023 Fab light chain[107 aa] | A | 100.0 /100.0 |
10 /10 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
8vr9[3] | E | R023 Fab heavy chain[117 aa] | A | 100.0 /100.0 |
4 /4 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
8vra[2] | C | RASK_HUMAN GTPase KRas, N-terminally processed[10 aa] | A | 100.0 /100.0 |
27 /27 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
8wte[6] | A | T-cell receptor alpha chain[183 aa] | C | 90.9 /97.4 |
11 /11 |
MHC class I antigen (Fragment) | |
8wte[6] | B | T-cell receptor beta chain[236 aa] | C | 100.0 /97.4 |
9 /9 |
MHC class I antigen (Fragment) | |
8rhq[3] | G | SPIKE_SARS2 Spike protein S2' [10 aa] | A | 87.1 /97.4 |
31 /31 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen | |
8i5c[10] | D | TCR alpha chain[198 aa] | A | 88.9 /96.7 |
9 /9 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) | |
8i5c[10] | E | TCR beta chain[240 aa] | A | 100.0 /96.7 |
10 /10 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) | |
8i5d[1] | A | TCR alpha chain[194 aa] | C | 84.6 /96.7 |
13 /13 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) | |
8i5d[1] | B | TCR beta chain[242 aa] | C | 100.0 /96.7 |
7 /7 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) | |
8i5e[1] | C | RASK_HUMAN KRAS-G12wt-9[9 aa] | A | 88.0 /96.7 |
25 /25 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) | |
1q94[7] | C | POL_HV1Z2 nonamer reverse transcriptase (AIFQSSMTK)[9 aa] | A | 86.2 /97.5 |
29 /29 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. | |
6id4[2] | J | peptide[9 aa] | A | 85.2 /97.4 |
27 /27 |
F6IQY1_HUMAN MHC class I antigen | |
4nqv[7] | M | Nucleoprotein[9 aa] | A | 81.5 /94.5 |
27 /27 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. | |
6j29[1] | B | MTB[9 aa] | A | 79.3 /96.0 |
29 /29 |
HLA-A*3003 | |
4nqx[6] | M | NP44-S7N mutant peptide, CTELKLNDY[9 aa] | A | 75.0 /94.5 |
28 /28 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. | |
1b0g[487] | B | B2MG_HUMAN BETA 2-MICROGLOBULIN[100 aa] | A | 94.1 /93.1 |
34 /34 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN | |
3bh9[2] | B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
6eny[1] | A | B2MG_HUMAN Beta-2-microglobulin[99 aa] | D | 100.0 /100.0 |
3 /3 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. | |
7phr[1] | G | B2MG_HUMAN Beta-2-microglobulin[99 aa] | F | 93.9 /93.1 |
33 /33 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
7tlt[11] | B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 93.9 /94.2 |
33 /33 |
B0UXQ0_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
8rh6[2] | F | B2MG_HUMAN Beta-2-microglobulin[98 aa] | A | 100.0 /97.5 |
1 /1 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen | |
1w72[3] | C | MAG1_HUMAN MELANOMA-ASSOCIATED ANTIGEN 1[9 aa] | A | 81.5 /94.5 |
27 /27 |
1A01_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN | |
1w72[2] | G | HYB3 HEAVY CHAIN[223 aa] | A | 88.9 /94.5 |
9 /9 |
1A01_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN | |
1w72[2] | I | HYB3 LIGHT CHAIN[210 aa] | A | 100.0 /94.5 |
6 /6 |
1A01_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN | |
5brz[1] | C | GLU-VAL-ASP-PRO-ILE-GLY-HIS-LEU-TYR[9 aa] | A | 80.0 /94.5 |
25 /25 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. | |
5brz[2] | D | A0A0B4J279_HUMAN TCA_HUMAN Protein TRAV21,T-cell receptor alpha chain C regio.. | A | 66.7 /94.5 |
9 /9 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. | |
5brz[2] | E | A0A578_HUMAN K7N5M4_HUMAN Protein TRBV5-1,Human nkt tcr beta chain[241 aa] | A | 80.0 /94.5 |
5 /5 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. | |
5bs0[1] | C | TITIN_HUMAN Titin[9 aa] | A | 78.3 /94.5 |
23 /23 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. | |
6at9[1] | C | ALK[10 aa] | A | 74.1 /94.5 |
27 /27 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. | |
6mpp[1] | B | NRAS Q61K peptide[10 aa] | A | 76.0 /94.5 |
25 /25 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. | |
8xke[1] | C | GLU-VAL-ASP-ASN-ALA-THR-ARG-PHE-ALA-SER-VAL-TYR[12.. | A | 75.0 /94.5 |
28 /28 |
HLA class I heavy chain | |
6ei2[1] | C | CCND2_HUMAN G1/S-specific cyclin-D2[10 aa] | A | 83.9 /94.2 |
31 /31 |
1A68_HUMAN HLA class I histocompatibility antigen, A-68 alpha.. | |
7tlt[2] | E | SPIKE_SARS2 Spike protein S1 peptide[9 aa] | A | 81.5 /94.2 |
27 /27 |
B0UXQ0_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
6pbh[1] | C | influenza A NP145-156 peptide[7 aa] | A | 79.2 /94.2 |
24 /24 |
1A68_HUMAN HLA class I histocompatibility antigen, A-68 alpha.. | |
1hsb[1] | C | BOUND PEPTIDE FRAGMENT[3 aa] | A | 75.0 /94.1 |
12 /12 |
A6YT91_HUMAN MHC class I antigen | |
8rbv[1] | C | SARS-CoV-2 Spike-derived peptide S976-984 S982A mu.. | A | 82.1 /93.1 |
28 /28 |
Q53Z42_HUMAN HLA class I antigen | |
1b0g[4] | C | PEPTIDE P1049 (ALWGFFPVL)[9 aa] | A | 79.3 /93.1 |
29 /29 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN | |
1bd2[14] | C | TAX PEPTIDE[9 aa] | A | 80.8 /93.1 |
26 /26 |
1A02_HUMAN HLA-A 0201 | |
1bd2[1] | D | T CELL RECEPTOR ALPHA[190 aa] | A | 88.9 /93.1 |
9 /9 |
1A02_HUMAN HLA-A 0201 | |
1bd2[14] | E | T CELL RECEPTOR BETA[242 aa] | A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA-A 0201 | |
2f53[1] | E | T-cell receptor, beta chain[243 aa] | A | 75.0 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen | |
7q9b[1] | E | Human T Cell Receptor Mel8, Beta Chain[245 aa] | F | 93.8 /93.1 |
16 /16 |
U5YJM1_HUMAN MHC class I antigen | |
1duy[2] | C | HTLV-1 OCTAMERIC TAX PEPTIDE[8 aa] | A | 81.0 /93.1 |
21 /21 |
1A02_HUMAN HLA-A2*0201 | |
1eey[2] | C | GP2 PEPTIDE[9 aa] | A | 84.6 /93.1 |
26 /26 |
1A02_HUMAN HLA-A2.1 MHC CLASS I (HEAVY CHAIN) | |
1eez[2] | C | GP2 PEPTIDE[9 aa] | A | 88.5 /93.1 |
26 /26 |
1A02_HUMAN HLA-A2.1 MHC CLASS I (HEAVY CHAIN) | |
1hhg[2] | C | ENV_HV1B8 HIV-1 GP120 ENVELOPE PROTEIN (RESIDUES 195-207)[9 .. | A | 79.2 /93.1 |
24 /24 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201) (A.. | |
1hhh[1] | C | CORA_HBVIL HEPATITIS B NUCLEOCAPSID PROTEIN (RESIDUES 18-27)[.. | A | 79.3 /93.1 |
29 /29 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201) (A.. | |
1hhi[13] | C | M1_IAPUE INFLUENZA A MATRIX PROTEIN M1 (RESIDUES 58-66)[9 a.. | A | 76.9 /93.1 |
26 /26 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201) (A.. | |
5euo[1] | I | M1_I34A1 Matrix protein 1[9 aa] | C | 76.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
1hhj[4] | C | POL_HV1MA HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309-317)[9 a.. | A | 82.1 /93.1 |
28 /28 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201) (A.. | |
1i1f[2] | C | PROTEIN (HIV-RT VARIANT PEPTIDE I1F (FLKEPVHGV))[9.. | A | 80.8 /93.1 |
26 /26 |
1A02_HUMAN PROTEIN (CLASS I HISTOCOMPATIBILITY ANTIGEN, GOGO-.. | |
1i1y[2] | C | HIV-RT VARIANT PEPTIDE I1Y (YLKEPVHGV)[9 aa] | A | 81.5 /93.1 |
27 /27 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN | |
1i4f[1] | C | MAGA4_HUMAN MELANOMA-ASSOCIATED ANTIGEN 4[10 aa] | A | 82.6 /93.1 |
23 /23 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. | |
8es8[2] | K | MAGA4_HUMAN Melanoma-associated antigen 4[10 aa] | I | 78.3 /93.1 |
23 /23 |
Q861F7_HUMAN MHC class I antigen | |
1i7r[2] | C | 9 RESIDUE PEPTIDE[9 aa] | A | 86.4 /93.1 |
22 /22 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. | |
1i7t[2] | C | 9 RESIDUE PEPTIDE[9 aa] | A | 87.5 /93.1 |
24 /24 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. | |
1i7u[2] | C | 9 RESIDUE PEPTIDE[9 aa] | A | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. | |
1im3[4] | D | US02_HCMVA cytomegalovirus protein US2[95 aa] | A | 92.3 /93.1 |
13 /13 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. | |
1lp9[2] | D | T-cell Receptor alpha chain[194 aa] | A | 91.7 /93.1 |
12 /12 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
1lp9[2] | E | T-cell Receptor beta chain[237 aa] | A | 88.9 /93.1 |
9 /9 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
1oga[6] | D | T-CELL RECEPTOR ALPHA CHAIN V REGION[200 aa] | A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN | |
5euo[1] | G | PF6 TCR alpha chain[191 aa] | C | 83.3 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
1oga[15] | E | TCB_HUMAN T-CELL RECEPTOR BETA CHAIN C REGION[241 aa] | A | 91.7 /93.1 |
12 /12 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN | |
7phr[1] | B | T-cell receptor beta chain[285 aa] | F | 90.0 /93.1 |
10 /10 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
1qew[1] | C | MAGA3_HUMAN PROTEIN (MELANOMA-ASSOCIATED ANTIGEN 3)[9 aa] | A | 87.5 /93.1 |
24 /24 |
1A02_HUMAN PROTEIN (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B.. | |
1qr1[2] | C | ERBB2_HUMAN GP2 PEPTIDE[9 aa] | A | 81.8 /93.1 |
22 /22 |
1A02_HUMAN HLA-A2.1 HEAVY CHAIN | |
1s8d[1] | C | gag peptide[9 aa] | A | 84.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
1t1w[4] | C | GAG PEPTIDE[9 aa] | A | 82.1 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
1t1x[1] | C | GAG PEPTIDE[9 aa] | A | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
1t1y[1] | C | GAG PEPTIDE[9 aa] | A | 84.6 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
1t1z[1] | C | GAG PEPTIDE[9 aa] | A | 84.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
1t20[3] | C | GAG PEPTIDE[9 aa] | A | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
1t21[5] | C | GAG PEPTIDE[9 aa] | A | 80.8 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
1tvb[4] | C | PME17_HUMAN epitope of Melanocyte protein Pmel 17[9 aa] | A | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
1tvh[4] | C | PME17_HUMAN epitope of Melanocyte protein Pmel 17[9 aa] | A | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
2bnq[7] | C | SYNTHETIC PEPTIDE[9 aa] | A | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN | |
6rp9[3] | C | CTG1B_HUMAN Cancer/testis antigen 1[9 aa] | A | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
2bnq[4] | D | T-CELL RECEPTOR ALPHA CHAIN V REGION[203 aa] | A | 85.7 /93.1 |
7 /7 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN | |
2bnr[3] | C | SYNTHETIC PEPTIDE[9 aa] | A | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN | |
2clr[2] | C | CRTC_HUMAN DECAMERIC PEPTIDE FROM CALRETICULIN[10 aa] | A | 78.6 /93.1 |
28 /28 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) (A.. | |
2git[3] | C | Transcriptional activator TAX[9 aa] | A | 85.2 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
2gj6[7] | D | A6-Tcr[200 aa] | A | 91.7 /93.1 |
12 /12 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
2gt9[5] | C | MAR1_HUMAN Melan-A/MART-1(26-35) peptide[10 aa] | A | 79.2 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen | |
2gtw[2] | C | MAR1_HUMAN octapeptide from Melan-A/MART-1[9 aa] | A | 78.3 /93.1 |
23 /23 |
1A02_HUMAN HLA-A*0201 heavy chain | |
2gtz[2] | C | MAR1_HUMAN octapeptide from Melan-A/MART-1[9 aa] | A | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA-A*0201 heavy chain | |
2guo[7] | C | MAR1_HUMAN Peptide[9 aa] | A | 81.0 /93.1 |
21 /21 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
6d78[1] | C | MAR1_HUMAN Melanoma antigen recognized by T-cells 1[9 aa] | A | 75.0 /93.1 |
20 /20 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
2v2x[2] | C | HIV P17[9 aa] | A | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. | |
2x4n[2] | C | HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[6 a.. | A | 81.8 /93.1 |
22 /22 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. | |
2x4o[2] | C | ENV_HV1MA ENVELOPE GLYCOPROTEIN GP160[9 aa] | A | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. | |
2x4p[4] | C | HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a.. | A | 76.0 /93.1 |
25 /25 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 | |
2x4r[2] | C | PP65_HCMVA 65 KDA PHOSPHOPROTEIN[9 aa] | A | 78.3 /93.1 |
23 /23 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 | |
2x4s[2] | C | H5N1 INFLUENZA A NUCLEOPROTEIN[9 aa] | A | 76.0 /93.1 |
25 /25 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 | |
2x4t[2] | C | PP65_HCMVA 65 KDA PHOSPHOPROTEIN[9 aa] | A | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 | |
2x70[2] | C | HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a.. | A | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 | |
3bh9[2] | C | POF1B_HUMAN decameric peptide from Protein POF1B[10 aa] | A | 80.8 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3d39[2] | C | Modified HTLV-1 TAX (Y5(4fluoro)F) peptide[9 aa] | A | 85.2 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3fqn[1] | C | peptide 30-39 from beta-Catenin: YLDSGIHSGA[8 aa] | A | 84.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3fqr[1] | C | phospho-peptide 30-39 from beta-Catenin: YLD(Sep)G.. | A | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3fqt[1] | C | peptide 38-46 from cell division cycle 25b (CDC25b.. | A | 83.3 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3fqu[1] | C | phospho-peptide 38-46 from cell division cycle 25b.. | A | 86.4 /93.1 |
22 /22 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3fqw[1] | C | peptide 1097-1105 from insulin receptor substrate .. | A | 76.9 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3fqx[1] | C | phospho-peptide 1097-1105 from insulin receptor s.. | A | 76.9 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3giv[2] | C | Q9YYH6_9HIV1 HIV-1 peptide[10 aa] | A | 84.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3h7b[3] | C | Tel1p peptide[9 aa] | A | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3hae[4] | M | Antibody light chain[211 aa] | A | 100.0 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3hae[5] | Q | Antibody heavy chain[220 aa] | A | 87.5 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3hg1[5] | C | CANCER/MART-1[10 aa] | A | 80.0 /93.1 |
25 /25 |
Q8WLS4_HUMAN MHC class I antigen | |
6dkp[1] | C | MAR1_HUMAN Melanoma antigen recognized by T-cells 1[10 aa] | A | 82.1 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3hg1[15] | D | T-CELL RECEPTOR, ALPHA CHAIN[194 aa] | A | 81.8 /93.1 |
11 /11 |
Q8WLS4_HUMAN MHC class I antigen | |
7q9b[1] | D | Human T Cell Receptor Mel8, Alpha Chain[193 aa] | F | 75.0 /93.1 |
4 /4 |
U5YJM1_HUMAN MHC class I antigen | |
3hg1[6] | E | T-cell Receptor, Beta Chain[244 aa] | A | 100.0 /93.1 |
7 /7 |
Q8WLS4_HUMAN MHC class I antigen | |
3hpj[3] | C | WT1_HUMAN WT126 peptide[9 aa] | A | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
4wuu[1] | C | ARG-MET-PHE-PRO-ASN-ALA-PRO-TYR-LEU[9 aa] | A | 84.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3i6g[2] | C | VME1_CVHSA Membrane protein[9 aa] | A | 78.6 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3kla[2] | C | CTG1B_HUMAN NYESO-1 peptide analogue[9 aa] | A | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3mgo[4] | C | 10-meric peptide from Hemagglutinin[10 aa] | A | 82.1 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3mgt[4] | C | Q1WDM0_9INFA 10-meric peptide from Hemagglutinin[10 aa] | A | 85.7 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3myj[2] | C | WT1_HUMAN Wilms tumor protein[9 aa] | A | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3o3a[4] | C | Peptidomimetic ELA-1[8 aa] | A | 76.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3o3b[4] | C | Peptidomimetic ELA-1.1[8 aa] | A | 78.6 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3o4l[1] | C | A7UMS0_EBVG BSLF2/BMLF1 protein[9 aa] | A | 83.3 /93.1 |
24 /24 |
Q8WLS4_HUMAN MHC class I antigen | |
3o4l[1] | D | T-CELL RECEPTOR, ALPHA CHAIN[195 aa] | A | 81.8 /93.1 |
11 /11 |
Q8WLS4_HUMAN MHC class I antigen | |
3o4l[1] | E | T-CELL RECEPTOR, BETA CHAIN[245 aa] | A | 85.7 /93.1 |
7 /7 |
Q8WLS4_HUMAN MHC class I antigen | |
8es9[1] | B | PN45428 TCR beta chain[287 aa] | I | 66.7 /93.1 |
3 /3 |
Q861F7_HUMAN MHC class I antigen | |
3pwj[2] | C | HuD (G2L,I9V) peptide[9 aa] | A | 82.8 /93.1 |
29 /29 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3pwl[3] | C | HuD peptide[9 aa] | A | 77.8 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3pwn[2] | C | HuD (G2L) peptide[9 aa] | A | 82.8 /93.1 |
29 /29 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3qdg[6] | E | DMF5 beta chain[242 aa] | A | 100.0 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3qdm[2] | D | DMF4 alpha chain[195 aa] | A | 87.5 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3qdm[2] | E | DMF4 beta chain[242 aa] | A | 85.7 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3qfj[1] | C | TAX(Y5F) peptide[9 aa] | A | 85.2 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3to2[1] | C | Q692E0_CVHSA Md3-C9 peptide derived from Membrane glycoprotein[.. | A | 82.6 /93.1 |
23 /23 |
Q53Z42_HUMAN MHC class I antigen | |
3utq[5] | C | INS_HUMAN Insulin[10 aa] | A | 80.8 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3uts[10] | D | 1E6 TCR Alpha Chain[200 aa] | A | 60.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5c07[2] | I | 1E6 TCR Alpha Chain[199 aa] | F | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3uts[12] | E | 1E6 TCR Beta Chain[246 aa] | A | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3v5d[2] | C | HIV peptide KVAELVHFL[9 aa] | A | 85.2 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3v5h[2] | C | HIV-based altered-peptide ligand KVAEIVHFL[9 aa] | A | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3v5k[2] | C | HIV-based altered-peptide ligand KVAELVWFL[9 aa] | A | 82.1 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
4e5x[2] | G | E3GL_ADE06 Early E3 18.5 kDa glycoprotein[99 aa] | A | 93.3 /93.1 |
15 /15 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
4gkn[1] | C | FAT Cognate peptide[10 aa] | A | 78.3 /93.1 |
23 /23 |
A0A5B8RNS7_HUMAN MHC class I antigen | |
4gks[1] | F | FLT Cognate peptide[10 aa] | D | 82.1 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
4i4w[1] | C | Immunogenic peptide[9 aa] | A | 79.3 /93.1 |
29 /29 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
4jfd[2] | C | Melanoma peptide[10 aa] | A | 80.8 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
4jfd[3] | D | High Affinity TCR Alpha Chain[196 aa] | A | 81.8 /93.1 |
11 /11 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
4jfo[2] | C | E1A heteroclitic Melanoma peptide[10 aa] | A | 80.8 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
4jfq[1] | C | L8A heteroclitic Melanoma peptide[10 aa] | A | 77.8 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
4k7f[1] | F | Q9QAC5_HBV Core protein[9 aa] | D | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
4l29[23] | F | NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa] | D | 83.3 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
4no5[1] | C | AMPD2_HUMAN AMP deaminase 2[9 aa] | A | 80.8 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
4uq3[2] | E | AZOBENZENE-CONTAINING PEPTIDE[6 aa] | A | 87.5 /93.1 |
24 /24 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. | |
4wj5[2] | C | MAR1_HUMAN Melanoma antigen recognized by T-cells 1[10 aa] | A | 82.1 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
4wuu[1] | D | ESK1[212 aa] | A | 66.7 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
4wuu[1] | E | IMMUNOGLOBULIN HEAVY CHAIN[223 aa] | A | 77.8 /93.1 |
18 /18 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5c07[2] | H | Marker peptide[10 aa] | F | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5c08[2] | C | Marker peptide[10 aa] | A | 77.8 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5c0a[1] | C | Marker peptide[10 aa] | A | 77.3 /93.1 |
22 /22 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5n1y[1] | C | MVWGPDPLYV[10 aa] | A | 76.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5c0b[2] | C | Marker peptide[10 aa] | A | 80.0 /93.1 |
30 /30 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5c0i[1] | C | Marker peptide[10 aa] | A | 80.0 /93.1 |
30 /30 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5c0c[1] | H | Marker peptide[10 aa] | F | 80.8 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5c0g[1] | C | Marker peptide[10 aa] | A | 87.5 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5e00[1] | C | GLY-VAL-TRP-ILE-ARG-THR-PRO-PRO-ALA[9 aa] | A | 81.8 /93.1 |
22 /22 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5eu3[1] | C | GP100 peptide YLEPGPVTA[9 aa] | A | 87.0 /93.1 |
23 /23 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5eu4[2] | C | Peptide antigen YLAPGPVTA[9 aa] | A | 87.0 /93.1 |
23 /23 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5eu6[1] | C | TYR-LEU-GLU-PRO-GLY-PRO-VAL-THR-VAL[9 aa] | A | 83.3 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
7phr[1] | H | PMEL_HUMAN Tumor-associated antigentic peptide gp100[9 aa] | F | 82.8 /93.1 |
29 /29 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
5eu6[1] | D | Human TCR Light Chain[204 aa] | A | 71.4 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5eu6[1] | E | Human TCR Heavy Chain[244 aa] | A | 90.0 /93.1 |
10 /10 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5hho[1] | E | M1-G4E, GILEFVFTL[9 aa] | A | 78.3 /93.1 |
23 /23 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5hyj[1] | C | ALA-GLN-TRP-GLY-PRO-ASP-PRO-ALA-ALA-ALA[10 aa] | A | 79.2 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5isz[1] | D | TCRalpha chain[200 aa] | A | 85.7 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5jhd[2] | D | TCRalpha chain[201 aa] | A | 87.5 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5meo[1] | C | ILE-LEU-GLY-LYS-PHE-LEU-HIS-ARG-LEU[9 aa] | A | 78.6 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5meq[1] | C | ILE-LEU-ALA-LYS-PHE-LEU-HIS-THR-LEU[9 aa] | A | 79.3 /93.1 |
29 /29 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5mer[1] | F | ILE-LEU-ALA-LYS-PHE-LEU-HIS-GLU-LEU[9 aa] | D | 82.1 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5n6b[1] | F | W8FN10_9FLAV NS5[9 aa] | D | 82.8 /93.1 |
29 /29 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5nme[3] | D | T-cell receptor Alpha chain[201 aa] | A | 83.3 /93.1 |
12 /12 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5nme[3] | E | Human T-cell receptor beta chain[242 aa] | A | 87.5 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5tez[1] | D | TCR F50 alpha chain[202 aa] | B | 100.0 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5tez[1] | E | TCR F50 beta chain[240 aa] | B | 87.5 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5yxn[3] | A | T cell receptor alpha chain[192 aa] | C | 77.8 /93.1 |
9 /9 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5yxn[3] | B | T cell receptor beta chain[241 aa] | C | 100.0 /93.1 |
10 /10 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5yxn[3] | E | NS3 peptide[10 aa] | C | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
6am5[1] | C | SER-MET-LEU-GLY-ILE-GLY-ILE-VAL-PRO-VAL[10 aa] | A | 79.2 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
6d78[1] | D | K7N5M3_HUMAN DMF5 alpha chain,DMF5 alpha chain[185 aa] | A | 83.3 /93.1 |
12 /12 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
6d7g[1] | B | Q6PJ56_HUMAN Q6PJ56_HUMAN TRA@ protein[198 aa] | A | 87.5 /93.1 |
8 /12 |
B2MG_HUMAN 1A02_HUMAN MART1 PEPTIDE-BETA-2-MICROGLOBULIN-HLA-A*02 CHIMER.. | |
6d7g[1] | C | T-CELL RECEPTOR GAMMA VARIABLE 8,T-CELL RECEPTOR G.. | A | 87.5 /93.1 |
8 /9 |
B2MG_HUMAN 1A02_HUMAN MART1 PEPTIDE-BETA-2-MICROGLOBULIN-HLA-A*02 CHIMER.. | |
6g3j[1] | F | MET-THR-SER-ALA-ILE-GLY-ILE-LEU-PRO-VAL[10 aa] | D | 81.8 /93.1 |
22 /22 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
6g3k[1] | F | ILE-THR-SER-GLY-ILE-GLY-VAL-LEU-PRO-VAL[10 aa] | D | 78.3 /93.1 |
23 /23 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
6nca[20] | J | RTA_EBVG Replication and transcription activator[9 aa] | AB | 82.6 /93.1 |
23 /23 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
6opd[1] | C | Melanoma antigen variant[9 aa] | A | 85.2 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
6ptb[2] | C | HAUS3_HUMAN HAUS augmin-like complex subunit 3[9 aa] | A | 80.8 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
6pte[4] | C | HAUS3_HUMAN HAUS augmin-like complex subunit 3[9 aa] | A | 82.1 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
6r2l[1] | C | SER-LEU-SER-LYS-ILE-LEU-ASP-THR-VAL[9 aa] | A | 87.5 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
6r2l[1] | D | TVA22_HUMAN K7N5M3_HUMAN T cell receptor alpha variable 22,Human nkt tcr al.. | A | 80.0 /93.1 |
15 /15 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
6r2l[1] | E | TVBK2_HUMAN K7N5M4_HUMAN T cell receptor beta variable 11-2,Human nkt tcr b.. | A | 87.5 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
6rp9[2] | D | T-cell receptor alpha chain[197 aa] | A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
6vm9[3] | D | T4H2 T cell receptor alpha chain[201 aa] | A | 81.8 /93.1 |
11 /11 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain | |
6rp9[2] | E | T-cell receptor beta chain[244 aa] | A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
6rpa[1] | D | T-cell receptor alpha chain[166 aa] | A | 71.4 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
6rpa[1] | E | T-cell receptor beta chain[235 aa] | A | 100.0 /93.1 |
11 /11 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
6rsy[1] | D | a7b2 ALPHA CHAIN[192 aa] | A | 80.0 /93.1 |
10 /10 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
6rsy[1] | E | DMF4 Beta CHAIN[242 aa] | A | 100.0 /93.1 |
11 /11 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
6ss8[1] | C | LEU-LEU-TRP-ASN-GLY-PRO-ILE-ALA-VAL[9 aa] | A | 78.6 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
6ss9[1] | C | LEU-LEU-TRP-ASN-GLY-PRO-MET-HIS-VAL[9 aa] | A | 84.6 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
6ssa[3] | C | LEU-LEU-TRP-ASN-GLY-PRO-MET-GLN-VAL[9 aa] | A | 82.1 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
6uz1[2] | I | T cell receptor, alpha chain[108 aa] | A | 100.0 /93.1 |
9 /9 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain | |
6uz1[2] | J | T cell receptor, beta chain[112 aa] | A | 83.3 /93.1 |
6 /6 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain | |
6vm7[2] | A | SILv44 T cell receptor alpha chain[197 aa] | C | 71.4 /93.1 |
7 /7 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain | |
6vmc[1] | E | PMEL_HUMAN Melanocyte protein PMEL[9 aa] | C | 82.8 /93.1 |
29 /29 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain | |
6vr1[2] | E | P53_HUMAN Cellular tumor antigen p53 peptide[9 aa] | A | 82.1 /93.1 |
28 /28 |
Q861F7_HUMAN MHC class I antigen | |
6vr5[2] | F | P53_HUMAN Cellular tumor antigen p53 peptide[9 aa] | C | 88.9 /93.1 |
27 /27 |
Q861F7_HUMAN MHC class I antigen | |
7rm4[4] | C | P53_HUMAN Cellular tumor antigen p53 peptide[9 aa] | A | 88.0 /93.1 |
25 /25 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
6w51[1] | S | Immunoglobulin heavy chain H2[222 aa] | J | 83.3 /93.1 |
6 /6 |
U5YKE0_HUMAN MHC class I antigen | |
6z9v[2] | C | ILE-ILE-GLY-TRP-MET-TRP-ILE-PRO-VAL[9 aa] | A | 76.9 /93.1 |
26 /26 |
A0A5B8RNS7_HUMAN MHC class I antigen | |
6z9w[2] | C | LEU-LEU-GLY-TRP-VAL-PHE-ALA-GLN-VAL[9 aa] | A | 87.5 /93.1 |
24 /24 |
U5YJM1_HUMAN MHC class I antigen | |
6z9x[2] | C | LEU-LEU-SER-TUR-PHE-GLY-THR-PRO-THR[9 aa] | A | 78.3 /93.1 |
23 /23 |
A0A5B8RNS7_HUMAN MHC class I antigen | |
7eu2[1] | F | SARS-CoV-2 T-cell Epitope S1[9 aa] | D | 80.0 /93.1 |
25 /25 |
A0A5H2UU57_HUMAN MHC class I antigen | |
7kgo[1] | C | NCAP_SARS2 Nucleoprotein[9 aa] | A | 83.3 /93.1 |
24 /24 |
Q861F7_HUMAN MHC class I antigen | |
7m8s[1] | C | SPIKE_SARS2 Spike protein S1 peptide[10 aa] | A | 80.0 /93.1 |
30 /30 |
Q861F7_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
7mj6[1] | C | IBPL1_HUMAN Insulin-like growth factor-binding protein-like 1 .. | A | 76.0 /93.1 |
25 /25 |
Q861F7_HUMAN MHC class I antigen | |
7mj7[1] | C | IBPL1_HUMAN Insulin-like growth factor-binding protein-like 1 .. | A | 80.8 /93.1 |
26 /26 |
Q861F7_HUMAN MHC class I antigen | |
7mj8[1] | C | IBPL1_HUMAN Insulin-like growth factor-binding protein-like 1 .. | A | 83.3 /93.1 |
24 /24 |
Q861F7_HUMAN MHC class I antigen | |
7mj9[1] | C | IBPL1_HUMAN Insulin-like growth factor-binding protein-like 1 .. | A | 87.0 /93.1 |
23 /23 |
Q861F7_HUMAN MHC class I antigen | |
7n1a[1] | C | SPIKE_SARS2 Spike protein S1[9 aa] | A | 77.8 /93.1 |
27 /27 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain | |
7n6d[5] | C | SPIKE_SARS2 Spike protein S1[9 aa] | A | 79.3 /93.1 |
29 /29 |
Q861F7_HUMAN MHC class I antigen | |
7p3e[2] | C | TYR-LEU-GLN-LEU-ARG-THR-PHE-LEU-LEU[9 aa] | A | 79.3 /93.1 |
29 /29 |
A0A5B8RNS7_HUMAN MHC class I antigen | |
7pbc[2] | D | T-cell receptor (TRBV/TRBC)[240 aa] | A | 83.3 /93.1 |
6 /6 |
Q861F7_HUMAN MHC class I antigen | |
7pbc[3] | E | MAGAA_HUMAN Melanoma-associated antigen 10[9 aa] | A | 80.8 /93.1 |
26 /26 |
Q861F7_HUMAN MHC class I antigen | |
7phr[1] | A | T-cell receptor alpha chain[243 aa] | F | 83.3 /93.1 |
12 /12 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
7q98[4] | C | ASN-LEU-SER-ALA-LEU-GLY-ILE-PHE-SER-THR[10 aa] | A | 82.1 /93.1 |
28 /28 |
A0A5B8RNS7_HUMAN MHC class I antigen | |
7q9a[1] | C | LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL-LEU[10 aa] | A | 82.1 /93.1 |
28 /28 |
A0A5B8RNS7_HUMAN MHC class I antigen | |
7re8[2] | C | PHE-MET-ASN-LYS-PHE-ILE-TYR-GLU-ILE[9 aa] | A | 82.8 /93.1 |
29 /29 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain | |
7rm4[4] | E | 6-11 T cell receptor alpha chain[200 aa] | A | 100.0 /93.1 |
6 /6 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
7tr4[1] | C | Light chain[211 aa] | A | 90.0 /93.1 |
10 /10 |
HLA-A*02:01 | |
7u1r[1] | C | SPIKE_SARS2 Spike protein S2' peptide [9 aa] | A | 86.2 /93.1 |
29 /29 |
Q53Z42_HUMAN HLA class I antigen | |
7u21[2] | C | PGM5 peptide (465-473) (H5Y)[9 aa] | A | 78.9 /93.1 |
19 /19 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain | |
7zuc[1] | C | LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL[9 aa] | A | 79.3 /93.1 |
29 /29 |
A0A5B8RNS7_HUMAN MHC class I antigen | |
8dnt[2] | B | T-cell receptor beta chain[242 aa] | D | 100.0 /93.1 |
5 /5 |
U5YKE0_HUMAN MHC class I antigen alpha chain | |
8dnt[2] | C | NCAP_SARS2 Nucleoprotein[9 aa] | D | 82.8 /93.1 |
29 /29 |
U5YKE0_HUMAN MHC class I antigen alpha chain | |
8eb2[2] | L | PA2.1 Fab Heavy Chain[215 aa] | A | 83.3 /93.1 |
12 /12 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain | |
8eb2[2] | M | PA2.1 Fab Light Chain[217 aa] | A | 66.7 /93.1 |
3 /3 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain | |
8es8[1] | G | PN45545 TCR alpha chain[257 aa] | I | 81.8 /93.1 |
11 /11 |
Q861F7_HUMAN MHC class I antigen | |
8es8[1] | H | PN45545 TCR beta chain[287 aa] | I | 100.0 /93.1 |
5 /5 |
Q861F7_HUMAN MHC class I antigen | |
8es9[1] | A | PN45428 TCR alpha chain[251 aa] | I | 100.0 /93.1 |
7 /7 |
Q861F7_HUMAN MHC class I antigen | |
8fu4[1] | C | TLF: TLFDEPPPL[9 aa] | A | 82.1 /93.1 |
28 /28 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain | |
8gom[1] | C | SPIKE_SARS2 Spike protein S2[9 aa] | A | 85.2 /93.1 |
27 /27 |
Q861F7_HUMAN MHC class I antigen | |
8gom[2] | D | SARS-CoV-2 specific private TCR RLQ7 alpha[191 aa].. | A | 80.0 /93.1 |
10 /10 |
Q861F7_HUMAN MHC class I antigen | |
8gom[2] | E | SARS-CoV-2 specific private TCR RLQ7 beta[244 aa] | A | 100.0 /93.1 |
11 /11 |
Q861F7_HUMAN MHC class I antigen | |
8gon[1] | C | SPIKE_SARS2 Spike protein S2[9 aa] | A | 82.1 /93.1 |
28 /28 |
Q861F7_HUMAN MHC class I antigen | |
8tbv[4] | C | Sorting nexin 24 (127-135)(P132L) peptide[9 aa] | A | 80.8 /93.1 |
26 /26 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain | |
8tbw[2] | C | Sorting nexin 24 (127-135) peptide[9 aa] | A | 83.3 /93.1 |
24 /24 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain | |
7sa2[1] | C | SPIKE_SARS2 Spike protein S2' peptide VVFLHVTYV [9 aa] | A | 80.8 /92.8 |
26 /26 |
Q861F7_HUMAN MHC class I antigen | |
7sis[1] | C | SPIKE_SARS2 Spike protein S2' peptide VLNDILSRL [9 aa] | A | 85.2 /92.8 |
27 /27 |
Q861F7_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
7kgp[1] | C | NCAP_SARS2 Nucleoprotein[9 aa] | A | 80.0 /92.4 |
25 /25 |
Q861F7_HUMAN MHC class I antigen | |
7kgs[1] | C | NCAP_SARS2 Nucleoprotein[9 aa] | A | 77.8 /92.4 |
27 /27 |
Q861F7_HUMAN MHC class I antigen | |
7kgt[1] | C | NCAP_SARS2 Nucleoprotein[3 aa] | A | 86.7 /92.4 |
15 /15 |
Q861F7_HUMAN MHC class I antigen | |
8xes[1] | C | A0A1U9YFU1_9PAPI Major capsid protein L1[9 aa] | A | 70.4 /92.3 |
27 /27 |
Q5SPM2_HUMAN HLA class I heavy chain | |
8xfz[1] | C | A0A1U9YFU1_9PAPI Major capsid protein L1[9 aa] | A | 76.7 /92.3 |
30 /30 |
Q5SPM2_HUMAN HLA class I heavy chain | |
8xg2[1] | C | SPIKE_SARS2 Spike protein S1[12 aa] | A | 75.0 /92.3 |
28 /28 |
Q5SPM2_HUMAN HLA class I heavy chain | |
8xkc[1] | C | SPIKE_SARS2 Spike protein S1[9 aa] | A | 66.7 /92.3 |
24 /24 |
Q5SPM2_HUMAN HLA class I heavy chain | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
COMPOUND | |||||||
365 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
8vr9[1] | F |
MOV
AMG 510 (bound form)[41 atoms] |
A | 100.0 /100.0 |
3 /3 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
8vra[1] | F |
MOV
AMG 510 (bound form)[41 atoms] |
A | 100.0 /100.0 |
4 /4 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
1hsb[1] | E |
ARG
ARGININE[12 atoms] |
A | 100.0 /94.1 |
11 /11 |
A6YT91_HUMAN MHC class I antigen | |
2gj6[1] | S |
3IB
3-INDOLEBUTYRIC ACID[14 atoms] |
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
4jfd[1] | F |
TAM
TRIS(HYDROXYETHYL)AMINOMETHANE[11 atoms] |
A | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
6tmo[1] | O |
TAM
TRIS(HYDROXYETHYL)AMINOMETHANE[11 atoms] |
A | 100.0 /93.1 |
5 /5 |
A0A5B8RNS7_HUMAN MHC class I antigen | |
6tmo[1] | Y |
TAM
TRIS(HYDROXYETHYL)AMINOMETHANE[11 atoms] |
A | 100.0 /93.1 |
3 /3 |
A0A5B8RNS7_HUMAN MHC class I antigen | |
6z9v[1] | Z |
PE8
3,6,9,12,15,18,21-HEPTAOXATRICOSANE-1,23-DIOL[25 a.. |
D | 70.0 /93.1 |
10 /10 |
A0A5B8RNS7_HUMAN MHC class I antigen | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
METAL | |||||||
365 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
2f53[1] | F |
NA
SODIUM ION[1 atoms] |
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen | |
3bh9[2] | D |
NA
SODIUM ION[1 atoms] |
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
4no5[2] | E |
NA
SODIUM ION[1 atoms] |
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
7kgp[2] | G |
NA
SODIUM ION[1 atoms] |
A | 66.7 /92.4 |
3 /3 |
Q861F7_HUMAN MHC class I antigen | |
7kgp[1] | H |
NA
SODIUM ION[1 atoms] |
A | 100.0 /92.4 |
1 /1 |
Q861F7_HUMAN MHC class I antigen | |
7kgp[1] | I |
NA
SODIUM ION[1 atoms] |
A | 100.0 /92.4 |
2 /2 |
Q861F7_HUMAN MHC class I antigen | |
7m8t[1] | F |
NA
SODIUM ION[1 atoms] |
A | 100.0 /97.5 |
2 /2 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
7tlt[1] | K |
NA
SODIUM ION[1 atoms] |
A | 100.0 /94.2 |
3 /3 |
B0UXQ0_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
7tlt[1] | M |
NA
SODIUM ION[1 atoms] |
C | 100.0 /94.2 |
1 /1 |
B0UXQ0_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
7u1r[1] | F |
NA
SODIUM ION[1 atoms] |
A | 100.0 /93.1 |
3 /3 |
Q53Z42_HUMAN HLA class I antigen | |
8rbu[1] | N |
NA
SODIUM ION[1 atoms] |
A | 100.0 /97.5 |
1 /1 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen | |
4l29[14] | TA |
CL
CHLORIDE ION[1 atoms] |
D | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
4l29[1] | FB |
CL
CHLORIDE ION[1 atoms] |
M | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
4l29[2] | GB |
CL
CHLORIDE ION[1 atoms] |
M | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
4l29[2] | UB |
CL
CHLORIDE ION[1 atoms] |
Y | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
4l3c[3] | RA |
CL
CHLORIDE ION[1 atoms] |
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
4l3c[2] | JC |
CL
CHLORIDE ION[1 atoms] |
EA | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
4l3c[1] | HB |
CL
CHLORIDE ION[1 atoms] |
M | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5wjl[2] | J |
CL
CHLORIDE ION[1 atoms] |
A | 50.0 /97.4 |
2 /2 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. | |
7kgo[1] | F |
CL
CHLORIDE ION[1 atoms] |
A | 100.0 /93.1 |
3 /3 |
Q861F7_HUMAN MHC class I antigen | |
7kgo[1] | G |
CL
CHLORIDE ION[1 atoms] |
A | 100.0 /93.1 |
2 /2 |
Q861F7_HUMAN MHC class I antigen | |
7m8t[1] | G |
CL
CHLORIDE ION[1 atoms] |
A | 100.0 /97.5 |
3 /3 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
8rbu[1] | K |
CL
CHLORIDE ION[1 atoms] |
A | 100.0 /97.5 |
4 /4 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen | |
8rhq[2] | W |
CL
CHLORIDE ION[1 atoms] |
C | 100.0 /97.4 |
6 /6 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen | |
8rhq[1] | DA |
CL
CHLORIDE ION[1 atoms] |
E | 83.3 /97.4 |
6 /6 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen | |
3fqn[3] | H |
MG
MAGNESIUM ION[1 atoms] |
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3fqn[4] | I |
MG
MAGNESIUM ION[1 atoms] |
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
6pbh[1] | E |
MG
MAGNESIUM ION[1 atoms] |
A | 100.0 /94.2 |
1 /1 |
1A68_HUMAN HLA class I histocompatibility antigen, A-68 alpha.. | |
7s8r[1] | G |
MG
MAGNESIUM ION[1 atoms] |
A | 100.0 /97.5 |
1 /1 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
7s8r[1] | I |
MG
MAGNESIUM ION[1 atoms] |
D | 100.0 /97.5 |
1 /1 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
7s8r[1] | J |
MG
MAGNESIUM ION[1 atoms] |
D | 100.0 /97.5 |
1 /1 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
7tlt[1] | I |
MG
MAGNESIUM ION[1 atoms] |
A | 100.0 /94.2 |
1 /1 |
B0UXQ0_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
7tlt[1] | L |
MG
MAGNESIUM ION[1 atoms] |
A | 50.0 /94.2 |
2 /2 |
B0UXQ0_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
6ei2[1] | F |
NI
NICKEL (II) ION[1 atoms] |
A | 0.0 /94.2 |
1 /1 |
1A68_HUMAN HLA class I histocompatibility antigen, A-68 alpha.. | |
6ei2[1] | I |
NI
NICKEL (II) ION[1 atoms] |
A | 100.0 /94.2 |
2 /2 |
1A68_HUMAN HLA class I histocompatibility antigen, A-68 alpha.. | |
3fqn[6] | D |
CD
CADMIUM ION[1 atoms] |
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3fqn[6] | E |
CD
CADMIUM ION[1 atoms] |
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3fqn[7] | F |
CD
CADMIUM ION[1 atoms] |
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3fqn[7] | G |
CD
CADMIUM ION[1 atoms] |
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3fqt[4] | D |
CD
CADMIUM ION[1 atoms] |
A | 0.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3fqt[7] | H |
CD
CADMIUM ION[1 atoms] |
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
6ei2[1] | G |
CD
CADMIUM ION[1 atoms] |
A | 100.0 /94.2 |
2 /2 |
1A68_HUMAN HLA class I histocompatibility antigen, A-68 alpha.. | |
6ei2[1] | H |
CD
CADMIUM ION[1 atoms] |
A | 100.0 /94.2 |
2 /2 |
1A68_HUMAN HLA class I histocompatibility antigen, A-68 alpha.. | |
7u1r[1] | D |
CD
CADMIUM ION[1 atoms] |
A | 100.0 /93.1 |
2 /2 |
Q53Z42_HUMAN HLA class I antigen | |
8rbv[1] | F |
CD
CADMIUM ION[1 atoms] |
A | 100.0 /93.1 |
2 /2 |
Q53Z42_HUMAN HLA class I antigen | |
8rbv[1] | G |
CD
CADMIUM ION[1 atoms] |
A | 0.0 /93.1 |
1 /1 |
Q53Z42_HUMAN HLA class I antigen | |
5c0e[1] | D |
BR
BROMIDE ION[1 atoms] |
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5mer[1] | CA |
CA
CALCIUM ION[1 atoms] |
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
6pbh[1] | D |
IOD
IODIDE ION[1 atoms] |
A | 100.0 /94.2 |
3 /3 |
1A68_HUMAN HLA class I histocompatibility antigen, A-68 alpha.. | |
7p3e[1] | G |
IOD
IODIDE ION[1 atoms] |
A | 100.0 /93.1 |
2 /2 |
A0A5B8RNS7_HUMAN MHC class I antigen | |
7p3e[2] | H |
IOD
IODIDE ION[1 atoms] |
A | 100.0 /93.1 |
2 /2 |
A0A5B8RNS7_HUMAN MHC class I antigen | |
7p3e[2] | I |
IOD
IODIDE ION[1 atoms] |
A | 100.0 /93.1 |
2 /2 |
A0A5B8RNS7_HUMAN MHC class I antigen | |
7p3e[1] | J |
IOD
IODIDE ION[1 atoms] |
A | 100.0 /93.1 |
1 /1 |
A0A5B8RNS7_HUMAN MHC class I antigen | |
7p3e[2] | K |
IOD
IODIDE ION[1 atoms] |
A | 100.0 /93.1 |
1 /1 |
A0A5B8RNS7_HUMAN MHC class I antigen | |
7p3e[1] | L |
IOD
IODIDE ION[1 atoms] |
A | 100.0 /93.1 |
2 /2 |
A0A5B8RNS7_HUMAN MHC class I antigen | |
7p3e[1] | M |
IOD
IODIDE ION[1 atoms] |
A | 100.0 /93.1 |
4 /4 |
A0A5B8RNS7_HUMAN MHC class I antigen | |
7p3e[1] | N |
IOD
IODIDE ION[1 atoms] |
A | 100.0 /93.1 |
2 /2 |
A0A5B8RNS7_HUMAN MHC class I antigen | |
7p3e[1] | FA |
IOD
IODIDE ION[1 atoms] |
D | 100.0 /93.1 |
1 /1 |
A0A5B8RNS7_HUMAN MHC class I antigen | |
7p3e[1] | T |
IOD
IODIDE ION[1 atoms] |
D | 100.0 /93.1 |
3 /3 |
A0A5B8RNS7_HUMAN MHC class I antigen | |
7p3e[1] | U |
IOD
IODIDE ION[1 atoms] |
D | 100.0 /93.1 |
2 /2 |
A0A5B8RNS7_HUMAN MHC class I antigen | |
7p3e[1] | W |
IOD
IODIDE ION[1 atoms] |
D | 100.0 /93.1 |
1 /1 |
A0A5B8RNS7_HUMAN MHC class I antigen | |
7p3e[1] | Z |
IOD
IODIDE ION[1 atoms] |
D | 100.0 /93.1 |
2 /2 |
A0A5B8RNS7_HUMAN MHC class I antigen | |
7kgo[1] | D |
3NI
NICKEL (III) ION[1 atoms] |
A | 100.0 /93.1 |
3 /3 |
Q861F7_HUMAN MHC class I antigen | |
7kgo[1] | E |
3NI
NICKEL (III) ION[1 atoms] |
A | 100.0 /93.1 |
2 /2 |
Q861F7_HUMAN MHC class I antigen | |
7sis[1] | F |
ZN
ZINC ION[1 atoms] |
A | 100.0 /92.8 |
2 /2 |
Q861F7_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
7u1r[1] | E |
ZN
ZINC ION[1 atoms] |
A | 100.0 /93.1 |
2 /2 |
Q53Z42_HUMAN HLA class I antigen | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
OTHERPOLY | |||||||
365 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
6eny[1] | F | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | D | 100.0 /100.0 |
4 /4 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. | |
7qpd[1] | G | alpha-D-glucopyranose-(1-3)-alpha-D-mannopyranose-.. | D | 100.0 /100.0 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
HOMO | |||||||
365 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
3bh9[2] | A | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | A | 90.9 /93.1 |
11 /11 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
8rh6[6] | C | Q5S3G3_HUMAN HLA class I histocompatibility antigen[275 aa] | A | 100.0 /97.5 |
2 /2 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen | |
8rh6[6] | E | Q5S3G3_HUMAN HLA class I histocompatibility antigen[275 aa] | A | 100.0 /97.5 |
5 /5 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
PRECIPITANT | |||||||
365 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
2git[1] | L |
FMT
FORMIC ACID[3 atoms] |
A | 50.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
2git[1] | P |
FMT
FORMIC ACID[3 atoms] |
D | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
2git[1] | Q |
FMT
FORMIC ACID[3 atoms] |
D | 50.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
2git[1] | R |
FMT
FORMIC ACID[3 atoms] |
D | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
2git[1] | S |
FMT
FORMIC ACID[3 atoms] |
D | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
2gtw[1] | I |
FMT
FORMIC ACID[3 atoms] |
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA-A*0201 heavy chain | |
2gtw[2] | J |
FMT
FORMIC ACID[3 atoms] |
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA-A*0201 heavy chain | |
2gtw[1] | M |
FMT
FORMIC ACID[3 atoms] |
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA-A*0201 heavy chain | |
7l1c[1] | F |
FMT
FORMIC ACID[3 atoms] |
A | 100.0 /100.0 |
4 /4 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
7l1c[1] | G |
FMT
FORMIC ACID[3 atoms] |
A | 100.0 /100.0 |
3 /3 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
3bh9[7] | E |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3bh9[213] | F |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 25.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
4gks[3] | V |
EDO
1,2-ETHANEDIOL[4 atoms] |
D | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
4i4w[1] | J |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
4i4w[2] | L |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
4i4w[10] | M |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 75.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5c0b[1] | SB |
EDO
1,2-ETHANEDIOL[4 atoms] |
F | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5c0c[4] | DA |
EDO
1,2-ETHANEDIOL[4 atoms] |
F | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5c0e[5] | G |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5c0e[1] | H |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
6o9b[1] | J |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 100.0 /99.6 |
5 /5 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. | |
7n6d[1] | Z |
EDO
1,2-ETHANEDIOL[4 atoms] |
J | 83.3 /93.1 |
6 /6 |
Q861F7_HUMAN MHC class I antigen | |
8rbu[1] | G |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 100.0 /97.5 |
3 /3 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen | |
8rh6[4] | K |
EDO
1,2-ETHANEDIOL[4 atoms] |
E | 100.0 /97.5 |
2 /2 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen | |
8rhq[1] | R |
EDO
1,2-ETHANEDIOL[4 atoms] |
C | 87.5 /97.4 |
8 /8 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen | |
8rhq[1] | U |
EDO
1,2-ETHANEDIOL[4 atoms] |
C | 100.0 /97.4 |
1 /1 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen | |
8ryo[1] | F |
TOE
2-[2-(2-METHOXY-ETHOXY)-ETHOXY]-ETHOXYL[11 atoms] |
A | 100.0 /100.0 |
3 /3 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
5euo[1] | K |
IMD
IMIDAZOLE[5 atoms] |
C | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
6o9b[1] | F |
IMD
IMIDAZOLE[5 atoms] |
A | 100.0 /99.6 |
7 /7 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. | |
6o9b[1] | G |
IMD
IMIDAZOLE[5 atoms] |
A | 100.0 /99.6 |
3 /3 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. | |
1x7q[30] | D |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /97.5 |
1 /1 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. | |
1x7q[30] | E |
SO4
SULFATE ION[5 atoms] |
A | 66.7 /97.5 |
3 /3 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. | |
2gj6[3] | F |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
2gj6[11] | J |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
2p5w[2] | F |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
3hg1[7] | H |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /93.1 |
3 /3 |
Q8WLS4_HUMAN MHC class I antigen | |
3o4l[3] | I |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /93.1 |
2 /2 |
Q8WLS4_HUMAN MHC class I antigen | |
3uts[1] | K |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
4gkn[6] | G |
SO4
SULFATE ION[5 atoms] |
A | 0.0 /93.1 |
2 /2 |
A0A5B8RNS7_HUMAN MHC class I antigen | |
4gkn[2] | H |
SO4
SULFATE ION[5 atoms] |
A | 66.7 /93.1 |
3 /3 |
A0A5B8RNS7_HUMAN MHC class I antigen | |
4jfd[1] | K |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5brz[1] | F |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /94.5 |
6 /6 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. | |
5brz[1] | G |
SO4
SULFATE ION[5 atoms] |
A | 71.4 /94.5 |
7 /7 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. | |
5bs0[2] | J |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /94.5 |
2 /2 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. | |
5c07[1] | U |
SO4
SULFATE ION[5 atoms] |
F | 100.0 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5c08[1] | BA |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5c08[1] | HA |
SO4
SULFATE ION[5 atoms] |
F | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5c0b[13] | U |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5c0b[2] | UA |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5e00[4] | D |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5eu4[1] | J |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5eu4[7] | T |
SO4
SULFATE ION[5 atoms] |
D | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5eu6[2] | N |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5mer[2] | IA |
SO4
SULFATE ION[5 atoms] |
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
6eqb[5] | I |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
6o9c[2] | F |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /99.6 |
3 /3 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. | |
6o9c[1] | G |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /99.6 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. | |
6o9c[2] | H |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /99.6 |
3 /3 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. | |
6pbh[2] | F |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /94.2 |
4 /4 |
1A68_HUMAN HLA class I histocompatibility antigen, A-68 alpha.. | |
6z9v[1] | L |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /93.1 |
4 /4 |
A0A5B8RNS7_HUMAN MHC class I antigen | |
7ow4[2] | O |
SO4
SULFATE ION[5 atoms] |
G | 100.0 /97.4 |
2 /2 |
A0A583ZB34_HUMAN MHC class I antigen | |
7q98[1] | S |
SO4
SULFATE ION[5 atoms] |
A | 85.7 /93.1 |
7 /7 |
A0A5B8RNS7_HUMAN MHC class I antigen | |
7q98[1] | OA |
SO4
SULFATE ION[5 atoms] |
G | 100.0 /93.1 |
5 /5 |
A0A5B8RNS7_HUMAN MHC class I antigen | |
8dvg[1] | N |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /100.0 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. | |
8rbu[1] | L |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /97.5 |
4 /4 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen | |
1hsb[1] | D |
ALA
ALANINE[5 atoms] |
A | 100.0 /94.1 |
2 /2 |
A6YT91_HUMAN MHC class I antigen | |
6opd[1] | D |
ACT
ACETATE ION[4 atoms] |
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
6opd[1] | E |
ACT
ACETATE ION[4 atoms] |
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
6opd[1] | F |
ACT
ACETATE ION[4 atoms] |
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
7kgp[1] | D |
ACT
ACETATE ION[4 atoms] |
A | 66.7 /92.4 |
3 /3 |
Q861F7_HUMAN MHC class I antigen | |
7kgs[2] | F |
ACT
ACETATE ION[4 atoms] |
A | 50.0 /92.4 |
2 /2 |
Q861F7_HUMAN MHC class I antigen | |
7kgt[1] | G |
ACT
ACETATE ION[4 atoms] |
A | 100.0 /92.4 |
5 /5 |
Q861F7_HUMAN MHC class I antigen | |
7l1d[1] | F |
ACT
ACETATE ION[4 atoms] |
A | 100.0 /100.0 |
1 /1 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. | |
7p3d[1] | F |
ACT
ACETATE ION[4 atoms] |
A | 100.0 /93.1 |
2 /2 |
A0A5B8RNS7_HUMAN MHC class I antigen | |
8rbv[1] | D |
ACT
ACETATE ION[4 atoms] |
A | 100.0 /93.1 |
4 /4 |
Q53Z42_HUMAN HLA class I antigen | |
8rbv[1] | H |
ACT
ACETATE ION[4 atoms] |
A | 100.0 /93.1 |
4 /4 |
Q53Z42_HUMAN HLA class I antigen | |
1i4f[1] | D |
1PG
2-(2-{2-[2-(2-METHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHO.. |
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. | |
1i4f[1] | E |
1PG
2-(2-{2-[2-(2-METHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHO.. |
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. | |
1tvb[402] | G |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
1tvb[1] | Q |
GOL
GLYCEROL[6 atoms] |
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
1tvb[1] | R |
GOL
GLYCEROL[6 atoms] |
D | 80.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
1tvh[1] | I |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
1tvh[1] | L |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
1tvh[1] | DA |
GOL
GLYCEROL[6 atoms] |
D | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
2gt9[19] | G |
GOL
GLYCEROL[6 atoms] |
A | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen | |
3o4l[11] | F |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /93.1 |
2 /2 |
Q8WLS4_HUMAN MHC class I antigen | |
3o4l[1] | G |
GOL
GLYCEROL[6 atoms] |
A | 66.7 /93.1 |
3 /3 |
Q8WLS4_HUMAN MHC class I antigen | |
5c07[1] | CA |
GOL
GLYCEROL[6 atoms] |
F | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5n1y[2] | Q |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
7qpj[1] | I |
GOL
GLYCEROL[6 atoms] |
A | 75.0 /93.1 |
4 /4 |
Q861F7_HUMAN MHC class I antigen | |
2x4n[25] | K |
MES
2-(N-MORPHOLINO)-ETHANESULFONIC ACID[12 atoms] |
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. | |
2x4n[8] | P |
MES
2-(N-MORPHOLINO)-ETHANESULFONIC ACID[12 atoms] |
D | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. | |
2x4u[1] | H |
MES
2-(N-MORPHOLINO)-ETHANESULFONIC ACID[12 atoms] |
A | 100.0 /93.1 |
7 /7 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. | |
4jfq[1] | N |
MES
2-(N-MORPHOLINO)-ETHANESULFONIC ACID[12 atoms] |
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5mer[1] | DA |
MES
2-(N-MORPHOLINO)-ETHANESULFONIC ACID[12 atoms] |
D | 0.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
6o9b[2] | E |
MES
2-(N-MORPHOLINO)-ETHANESULFONIC ACID[12 atoms] |
A | 100.0 /99.6 |
4 /4 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. | |
4jfp[1] | U |
EPE
4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACI.. |
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5n6b[1] | W |
EPE
4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACI.. |
D | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
6eqb[1] | F |
EPE
4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACI.. |
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
6eqb[1] | G |
EPE
4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACI.. |
A | 75.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
4uq3[1] | G |
IPA
ISOPROPYL ALCOHOL[4 atoms] |
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. | |
4uq3[1] | H |
IPA
ISOPROPYL ALCOHOL[4 atoms] |
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. | |
4uq3[2] | I |
IPA
ISOPROPYL ALCOHOL[4 atoms] |
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. | |
4uq3[1] | K |
IPA
ISOPROPYL ALCOHOL[4 atoms] |
C | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. | |
4uq3[1] | L |
IPA
ISOPROPYL ALCOHOL[4 atoms] |
C | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. | |
5c0e[3] | DA |
PG4
TETRAETHYLENE GLYCOL[13 atoms] |
A | 80.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5c0e[4] | EA |
PG4
TETRAETHYLENE GLYCOL[13 atoms] |
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5c0e[2] | FA |
PG4
TETRAETHYLENE GLYCOL[13 atoms] |
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5c0e[1] | IA |
PG4
TETRAETHYLENE GLYCOL[13 atoms] |
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5c0e[1] | U |
PG4
TETRAETHYLENE GLYCOL[13 atoms] |
A | 80.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5c0e[1] | V |
PG4
TETRAETHYLENE GLYCOL[13 atoms] |
A | 100.0 /93.1 |
9 /9 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5c0e[1] | W |
PG4
TETRAETHYLENE GLYCOL[13 atoms] |
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5c0e[1] | X |
PG4
TETRAETHYLENE GLYCOL[13 atoms] |
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
5c0e[1] | Y |
PG4
TETRAETHYLENE GLYCOL[13 atoms] |
A | 100.0 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
7n1a[1] | G |
PG4
TETRAETHYLENE GLYCOL[13 atoms] |
A | 100.0 /93.1 |
3 /3 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain | |
5n6b[2] | BA |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
D | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
6id4[7] | L |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 100.0 /97.4 |
5 /5 |
F6IQY1_HUMAN MHC class I antigen | |
6id4[2] | Q |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
E | 83.3 /97.5 |
6 /6 |
F6IQY1_HUMAN MHC class I antigen | |
6o9b[1] | H |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 100.0 /99.6 |
5 /5 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. | |
6o9b[2] | I |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 100.0 /99.6 |
4 /4 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. | |
6o9b[4] | Q |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 100.0 /99.6 |
4 /4 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. | |
6r2l[1] | F |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
6ss8[1] | Q |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
6ssa[1] | R |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
D | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | |
7p3e[1] | O |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 100.0 /93.1 |
3 /3 |
A0A5B8RNS7_HUMAN MHC class I antigen | |
7p3e[1] | AA |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
D | 66.7 /93.1 |
3 /3 |
A0A5B8RNS7_HUMAN MHC class I antigen | |
7q98[3] | P |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 100.0 /93.1 |
2 /2 |
A0A5B8RNS7_HUMAN MHC class I antigen | |
7q98[1] | T |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 100.0 /93.1 |
2 /2 |
A0A5B8RNS7_HUMAN MHC class I antigen | |
7q98[2] | QA |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
G | 100.0 /93.1 |
4 /4 |
A0A5B8RNS7_HUMAN MHC class I antigen | |
7re8[2] | H |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 100.0 /93.1 |
4 /4 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain | |
7re8[1] | J |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 100.0 /93.1 |
5 /5 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain | |
7re8[1] | K |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 100.0 /93.1 |
3 /3 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain | |
7re8[1] | T |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
E | 80.0 /93.1 |
5 /5 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain | |
8dvg[1] | K |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 100.0 /100.0 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. | |
8rbu[1] | D |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 100.0 /97.5 |
2 /2 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen | |
8rbv[1] | J |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 100.0 /93.1 |
3 /3 |
Q53Z42_HUMAN HLA class I antigen | |
8rh6[1] | J |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
E | 100.0 /97.5 |
4 /4 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen | |
8rhq[1] | V |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
C | 100.0 /97.4 |
3 /3 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen | |
8tbv[1] | G |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 100.0 /93.1 |
5 /5 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain | |
8u9g[1] | G |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 100.0 /93.1 |
3 /3 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain | |
6vm8[1] | F |
FLC
CITRATE ANION[13 atoms] |
A | 100.0 /93.1 |
1 /1 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain | |
6z9v[1] | Q |
P4G
1-ETHOXY-2-(2-ETHOXYETHOXY)ETHANE[11 atoms] |
A | 100.0 /93.1 |
4 /4 |
A0A5B8RNS7_HUMAN MHC class I antigen | |
6z9v[1] | Y |
P4G
1-ETHOXY-2-(2-ETHOXYETHOXY)ETHANE[11 atoms] |
D | 50.0 /93.1 |
2 /2 |
A0A5B8RNS7_HUMAN MHC class I antigen | |
7re8[2] | G |
PGE
TRIETHYLENE GLYCOL[10 atoms] |
A | 100.0 /93.1 |
4 /4 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain | |
7re8[1] | N |
PGE
TRIETHYLENE GLYCOL[10 atoms] |
A | 100.0 /93.1 |
4 /4 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain | |
7re8[3] | O |
PGE
TRIETHYLENE GLYCOL[10 atoms] |
A | 57.1 /93.1 |
7 /7 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain | |
7re8[2] | I |
1PE
PENTAETHYLENE GLYCOL[16 atoms] |
A | 100.0 /93.1 |
3 /3 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain | |
8tbw[2] | G |
NO3
NITRATE ION[4 atoms] |
A | 100.0 /93.1 |
4 /4 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. |